PC(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Term ID

CHEBI:89558

Synonyms

1-g-Linolenoyl-2-linoleoyl-sn-glycero-3-phosphocholine
1-gamma-Linolenoyl-2-linoleoyl-sn-glycero-3-phosphocholine
GPCho(18:3/18:2)
GPCho(18:3n6/18:2n6)
GPCho(18:3w6/18:2w6)
GPCho(36:5)
Lecithin
PC aa C36:5
PC(18:3/18:2)
PC(18:3n6/18:2n6)
PC(18:3w6/18:2w6)
PC(36:5)
Phosphatidylcholine(18:3/18:2)
Phosphatidylcholine(18:3n6/18:2n6)
Phosphatidylcholine(18:3w6/18:2w6)
Phosphatidylcholine(36:5)
trimethyl(2-{[(2R)-3-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)azanium

(all 17)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphocholine

1,2-diacyl-sn-glycero-3-phosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Phenotype where environments contain PC(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Phenotype modified by environments containing PC(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Phenotype affecting PC(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))

Human Disease Model